Needle-free treatment plan
Semaglutide Oral Plan
Current options shown after evaluation*
*Available plan types, payment timing, supply options, and pricing differ by treatment and can change. Current terms are shown during the secure evaluation.
Weight management
Needle-free treatment support for a clinician-guided weight plan.*
Oral semaglutide supports appetite regulation and clinically guided weight management in a needle-free format.*
*Available plan types, payment timing, supply options, and pricing differ by treatment and can change. Current terms are shown during the secure evaluation.
*Results and eligibility differ by individual. Prescription treatment requires an evaluation by an independent licensed provider. Compounded medications are not FDA-approved and are prepared by a licensed pharmacy when clinically appropriate.
Reviewed by Kurea Care clinical and compliance review

At a glance
Semaglutide
An oral compounded format supports a clinician-guided weight management plan.*
Individual plan
A provider reviews response and tolerability and adjusts the plan when clinically appropriate.
Flexible plan options
Available packs, payment timing, supply options, and plan structures differ by treatment and can change. Current terms appear during the secure evaluation.
Needle-free treatment plan
Current options shown after evaluation*
*Available plan types, payment timing, supply options, and pricing differ by treatment and can change. Current terms are shown during the secure evaluation.
Treatment information
Oral semaglutide supports appetite regulation and a clinician-guided weight management plan in a needle-free compounded format.* Treatment includes provider evaluation and ongoing guidance based on individual response and tolerability.
Semaglutide activates GLP-1 pathways involved in appetite and food intake.* A licensed provider determines eligibility, selects the formulation and starting plan, and adjusts treatment when clinically appropriate.
This option is designed for eligible adults who prefer a needle-free format and whose health history supports prescription treatment. A provider reviews medical history, current medicines, pregnancy plans, prior weight treatment, and other clinical factors before prescribing.
Tell the provider about a personal or family history of medullary thyroid carcinoma or MEN 2, pancreatitis, gallbladder or kidney problems, severe stomach symptoms, pregnancy plans, and all current medicines. Seek medical care for severe or persistent abdominal pain, a serious allergic reaction, or concerning symptoms. Compounded oral semaglutide is not FDA-approved.
Formulation
The licensed provider reviews the complete formulation, dose, health history, and current medicines before prescribing.
Active ingredient
GLP-1 receptor agonist
Supports appetite regulation and food-intake pathways as part of a clinician-guided weight management plan.*
Frequently asked questions
Private clinician-guided care
Complete a secure intake. An independent licensed provider reviews eligibility and determines whether treatment is appropriate.
*Results and eligibility differ by individual. Prescription treatment requires an evaluation by an independent licensed provider. Compounded medications are not FDA-approved and are prepared by a licensed pharmacy when clinically appropriate.